Recent advances in the treatment of hormone receptor-positive/human epidermal growth factor 2-positive advanced breast cancer

Hormone receptor (HR)-positive/human epidermal growth factor receptor 2 (HER2)-positive (HR+/HER2+) advanced breast cancer is a special subtype of cancer with unique features. Major guidelines recommend that combination therapy containing anti-HER2 therapy (e.g., trastuzumab and pertuzumab) should b...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Huimin, Yan, Min, Jiang, Zefei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111512/
https://www.ncbi.nlm.nih.gov/pubmed/33995599
http://dx.doi.org/10.1177/17588359211013326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111512/
https://www.ncbi.nlm.nih.gov/pubmed/33995599
http://dx.doi.org/10.1177/17588359211013326

Ejemplares similares